Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients
Mittendorf, E.A., Clifton, G.T., Holmes, J.P., Schneble, E., van Echo, D., Ponniah, S., Peoples, G.E.
Published in Annals of oncology (01.09.2014)
Published in Annals of oncology (01.09.2014)
Get full text
Journal Article
Increased Notching of the Corpus Callosum in Fetal Alcohol Spectrum Disorder: A Callosal Misunderstanding?
Schneble, E, Lack, C, Zapadka, M, Pfeifer, C M, Bardo, D M E, Cagley, J, Acharya, J, Klein, A P, Bhalla, M, Obayashi, J T, Ross, D, Pettersson, D R, Pollock, J M
Published in American journal of neuroradiology : AJNR (01.04.2020)
Published in American journal of neuroradiology : AJNR (01.04.2020)
Get full text
Journal Article
Phase I trial results of a folate receptor alpha-directed cancer vaccine (E39) in ovarian and endometrial cancer patients to prevent recurrence
Schneble, E, Ponniah, S, McGuire, W.P, Conrads, T.P, Elkas, J.C, Darcy, K.M, Maxwell, G.L, Hamilton, C.A, Peoples, G
Published in Gynecologic oncology (01.06.2014)
Published in Gynecologic oncology (01.06.2014)
Get full text
Journal Article
Interim safety analysis of a phase II trial combining trastuzumab and NeuVax, a HER2-targeted peptide vaccine, to prevent breast cancer recurrence in HER2 low expression
Jackson, D.O., Peace, K.M., Hale, D.F., Vreeland, T.J., Choy, G., Nejadnik, B., Greene, J.M., Schneble, E.J., Berry, J.S., Trappey, A.F., Hardin, M.O., Clifton, G.T., Herbert, G.S., Mittendorf, E., Holmes, J.P., Peoples, G.E.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients
Mittendorf, E A, Clifton, G T, Holmes, J P, Schneble, E, van Echo, D, Ponniah, S, Peoples, G E
Published in Annals of oncology (01.09.2014)
Get full text
Published in Annals of oncology (01.09.2014)
Journal Article
Abstract P2-11-01: Final pre-specified analysis of the phase II trial of the GP2+GM-CSF peptide vaccine in high risk breast cancer patients to prevent recurrence
Greene, JM, Schneble, EJ, Perez, S, Murray, JL, Berry, JS, Trappey, AF, Hale, DF, Vreeland, TJ, Clifton, GT, Ardavanis, A, Litton, JK, Shumway, NM, Papamichail, M, Peoples, GE, Mittendorf, EA
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article
Abstract P4-13-02: Preliminary results for the phase 1 trial of a dual HER2 peptide cancer vaccine in breast and ovarian cancer patients
Berry, JS, Trappey, AF, Vreeland, TJ, Schneble, EJ, Clifton, GT, Hale, DF, Sears, AK, Ponniah, S, Shumway, NM, Mittendorf, EA, Peoples, GE
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Get full text
Journal Article
Abstract P2-14-01: Breast cancer patients with HER2 low-expression: An under-recognized group at significant risk for recurrence
Vreeland, TJ, John, BS, Trappey, AF, Schneble, EJ, Hale, DF, Clifton, GT, Shumway, NM, Perez, SA, Papamichail, M, Ponniah, S, Peoples, GE, Mittendorf, EA
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Get full text
Journal Article